Successful Early Rituximab Treatment in a Case of Systemic Lupus Erythematosus with Potentially Fatal Diffuse Alveolar Hemorrhage
- Authors
- Na, Ju Ock; Chang, Sung Hae; Seo, Ki-Hyeon; Choi, Jae Sung; Lee, Ho Sung; Lyu, Ji Won; Nah, Seoung-Su
- Issue Date
- 2015
- Publisher
- Karger AG
- Keywords
- Systemic lupus erythematosus; Diffuse alveolar hemorrhage; Rituximab
- Citation
- Respiration; international review of thoracic diseases, v.89, no.1, pp 62 - 65
- Pages
- 4
- Journal Title
- Respiration; international review of thoracic diseases
- Volume
- 89
- Number
- 1
- Start Page
- 62
- End Page
- 65
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11535
- DOI
- 10.1159/000369038
- ISSN
- 0025-7931
1423-0356
- Abstract
- Diffuse alveolar hemorrhage (DAH) is a rare but devastating complication of systemic lupus erythematosus (SLE) with a high early mortality rate. DAH seldom occurs without active organ involvement. Recently, rituximab (RTX), a B cell-targeted therapy, has been reported to be effective for life-threatening autoimmune diseases. We describe a SLE patient who presented with acute respiratory failure due to DAH without other active organ involvement. This condition was dramatically improved with RTX without cyclophosphamide. (C) 2014 S. Karger AG, Basel
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11535)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.